SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sunil Healthcare informs about newspaper publication

15 Feb 2025 Evaluate
Pursuant to Regulation 47, 30 and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sunil Healthcare has enclosed copies of the Newspaper Publication for the Un-audited Financial Results (standalone and consolidated) for 3rd quarter/nine months ended on December 31, 2024 published in Newspapers viz. Pioneer on February 15, 2025 both Hindi & English edition. The aforesaid information will also be uploaded on the Company's website at https://www.sunilhealthcare.com

The above information is a part of company’s filings submitted to BSE.

Sunil Healthcare Share Price

65.40 1.20 (1.87%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×